Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for OKAI.V.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
September 30, 2024 1.427M
June 30, 2024 1.289M
March 31, 2024 1.330M
December 31, 2023
September 30, 2023 1.442M
June 30, 2023 1.321M
March 31, 2023 0.2788M
December 31, 2022 0.90M
September 30, 2022 0.1014M
June 30, 2022 0.0917M
March 31, 2022 0.0255M
December 31, 2021 0.0181M
September 30, 2021 0.0197M
June 30, 2021 0.0186M
March 31, 2021 0.0189M
December 31, 2020 0.0205M
September 30, 2020 0.0208M
June 30, 2020 0.0189M
March 31, 2020 0.0306M
December 31, 2019 0.0168M
September 30, 2019 0.011M
June 30, 2019 0.0177M
March 31, 2019 0.0173M
December 31, 2018 0.0173M
Date Value
September 30, 2018 0.0188M
June 30, 2018 0.0193M
March 31, 2018 0.0229M
December 31, 2017 0.0282M
September 30, 2017 0.0108M
June 30, 2017 0.0497M
March 31, 2017 0.1218M
December 31, 2016 0.1093M
September 30, 2016 0.0809M
June 30, 2016 0.0707M
March 31, 2016 0.2232M
December 31, 2015 0.6514M
September 30, 2015 0.6282M
June 30, 2015 0.4845M
March 31, 2015 0.3664M
December 31, 2014 0.2925M
September 30, 2014 0.2665M
June 30, 2014 0.1198M
March 31, 2014 0.1009M
December 31, 2013
September 30, 2013
June 30, 2013
March 31, 2013 1.592M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Diagnos, Inc. 1.704M
Arch Biopartners, Inc. 4.107M
Avricore Health, Inc. 0.3892M
Kane Biotech, Inc. 3.229M
CardioComm Solutions, Inc. 0.8445M